An emerging new paradigm in opioid withdrawal: A critical role for glia-neuron signaling in the periaqueductal gray

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Ouyang, Handong ^a   Liu, Shue ^a,b   Zeng, Weian ^c   Levitt, Roy C ^b   Candiotti, Keith A ^b   Hao, Shuanglin ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ENKEPHALIN; MORPHINE; NALOXONE; NEUROTRANSMITTER; PREPROENKEPHALIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AMYGDALOID NUCLEUS; BRAIN FUNCTION; CELL ACTIVATION; CELL COMMUNICATION; CELL INTERACTION; CYTOKINE RELEASE; DRUG WITHDRAWAL; GABAERGIC SYSTEM; GLIA CELL; HUMAN; HYPOTHALAMUS; LOCUS CERULEUS; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBENS; PERIAQUEDUCTAL GRAY MATTER; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME; ANIMAL; GLIA; METABOLISM; NERVE CELL; OPIATE ADDICTION;

ANIMALS; HUMANS; NEUROGLIA; NEURONS; OPIOID-RELATED DISORDERS; PERIAQUEDUCTAL GRAY; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84866174963     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/940613     Document Type: Review

References (94)

1. Chu L. F., Liang D. Y., Li X., Sahbaie P., D'Arcy N., Liao G., Peltz G., Clark J. D., From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenetics and Genomics 2009 19 3 193 205 2-s2.0-62349093322 10.1097/FPC.0b013e328322e73d
2. Koob G. F., Le Moal M., Drug abuse: Hedonic homeostatic dysregulation. Science 1997 278 5335 52 58 2-s2.0-0030756351 10.1126/science.278.5335.52 (Pubitemid 27446270)
3. Cami J., Farre M., Drug addiction. The New England Journal of Medicine 2003 349 975 986 10.1056/NEJMra023160 (Pubitemid 37064772)
4. Kvist A., Fagergren P., Whittard J., Garcia-Osta A., Drakenberg K., Horvath M. C., Schmidt C. J., Keller E., Bannon M. J., Hurd Y. L., Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers. Biological Psychiatry 2011 69 3 245 252 2-s2.0-78650826178 10.1016/j.biopsych.2010.09.037
5. Ingram S. L., Vaughan C. W., Bagley E. E., Connor M., Christie M. J., Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. Journal of Neuroscience 1998 18 24 10269 10276 2-s2.0-0032535012 (Pubitemid 29016546)
6. Hao S., Liu S., Zheng X., Zheng W., Ouyang H., Mata M., Fink D. J., The role of TNF α in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats. Neuropsychopharmacology 2011 36 3 664 676 2-s2.0-78651401018 10.1038/npp.2010.197
7. Cushman P., Dole V. P., Detoxification of rehabilitated methadone maintained patients. Journal of the American Medical Association 1973 226 7 747 752 2-s2.0-0015842787 10.1001/jama.226.7.747
8. Morgan M. M., Christie M. J., Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. British Journal of Pharmacology 2011 164 1322 1334 10.1111/j.1476-5381.2011.01335.x
9. Kirby K. C., Stitzer M. L., Heishman S. J., Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II. Journal of Pharmacology and Experimental Therapeutics 1990 255 2 730 737 2-s2.0-0025242933
10. Preston K. L., Bigelow G. E., Liebson I. A., Effects of sublingually given naloxone in opioid-dependent human volunteers. Drug and Alcohol Dependence 1990 25 1 27 34 2-s2.0-0025254241 10.1016/0376-8716(90)90136-3 (Pubitemid 20086950)
11. Laschka E., Teschemacher Hj., Mehraein P., Herz A., Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas. Psychopharmacologia 1976 46 2 141 147 2-s2.0-0017262797
12. Koob G. F., Maldonado R., Stinus L., Neural substrates of opiate withdrawal. Trends in Neurosciences 1992 15 5 186 191 2-s2.0-0026597790 10.1016/0166-2236(92)90171-4
13. McPhie A. A., Barr G. A., Regional Fos expression induced by morphine withdrawal in the 7-day-old rat. Developmental Psychobiology 2009 51 7 544 552 2-s2.0-70350532628 10.1002/dev.20392
14. Keay K. A., Bandler R., Paxinos G., Periaqueductal Gray. The Rat Nervous System 2004 3rd New York, NY, USA Elsevier Academic Press 243 257
15. Floyd N. S., Keay K. A., Bandler R., A calbindin immunoreactive 'deep pain' recipient thalamic nucleus in the rat. NeuroReport 1996 7 2 622 626 2-s2.0-0029962852 (Pubitemid 26105052)
16. Krout K. E., Loewy A. D., Periaqueductal gray matter projections to midline and intralaminar thalamic nuclei of the rat. The Journal of Comparative Neurology 2000 424 111 141 10.1002/1096-9861(20000814)424:1<111::AID- CNE9>3.0.CO;2-3 (Pubitemid 30602078)
17. Bandler R., Shipley M. T., Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends in Neurosciences 1994 17 9 379 389 2-s2.0-0028101302 10.1016/0166-2236(94)90047-7 (Pubitemid 24256076)
18. Vaughan C. W., Christie M. J., Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductalgrey in vitro. Journal of Physiology 1997 498 2 463 472 2-s2.0-0031033471 (Pubitemid 27073390)
19. Maldonado R., Stinus L., Gold L. H., Koob G. F., Role of different brain structures in the expression of the physical morphine withdrawal syndrome. Journal of Pharmacology and Experimental Therapeutics 1992 261 2 669 677 2-s2.0-0026773463
20. Bozarth M. A., Physical dependence produced by central morphine infusions: an anatomical mapping study. Neuroscience and Biobehavioral Reviews 1994 18 3 373 383 2-s2.0-0027991284 10.1016/0149-7634(94)90050-7 (Pubitemid 24258709)
21. Wei E., Loh H., Physical dependence on opiate like peptides. Science 1976 193 4259 1262 1263 2-s2.0-0017189140
22. Stornetta R. L., Norton F. E., Guyenet P. G., Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Research 1993 624 1-2 19 28 2-s2.0-0027242098 (Pubitemid 23281797)
23. Chieng B., Keay K. A., Christie M. J., Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal. Neuroscience Letters 1995 183 1-2 79 82 2-s2.0-0028813520 10.1016/0304-3940(94)11119-4
24. Couceyro P., Douglass J., Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain. Molecular Pharmacology 1995 47 1 29 39 2-s2.0-0028897182
25. Chieng B., Christie M. J., Local opioid withdrawal in rat single periaqueductal gray neurons in vitro. Journal of Neuroscience 1996 16 22 7128 7136 2-s2.0-0029822432 (Pubitemid 26382890)
26. Fukunaga Y., Kishioka S., Enkephalinergic neurons in the periaqueductal gray and morphine withdrawal. Japanese Journal of Pharmacology 2000 82 3 175 180 2-s2.0-0034033384 10.1254/jjp.82.175 (Pubitemid 30209524)
27. Sonnenberg J. L., Rauscher F. J. III, Morgan J. I., Curran T., Regulation of proenkephalin by Fos and Jun. Science 1989 246 4937 1622 1625 2-s2.0-0024806589 (Pubitemid 20036701)
28. Fukunaga Y., Nishida S., Inoue N., Miyamoto M., Kishioka S., Yamamoto H., Time course of morphine withdrawal and preproenkephalin gene expression in the periaqueductal gray of rats. Molecular Brain Research 1998 55 2 221 231 2-s2.0-0032052713 10.1016/S0169-328X(97)00374-4 (Pubitemid 28248038)
29. Haydon P. G., Blendy J., Moss S. J., Rob Jackson F., Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse? Neuropharmacology 2009 56 supplement 1 83 90 2-s2.0-58049155415 10.1016/j.neuropharm.2008.06.050
30. Guo M., Pascual R. M., Wang S., Fontana M. F., Valancius C. A., Panettieri R. A., Tilley S. L., Penn R. B., Cytokines regulate β -2-adrenergic receptor responsiveness in airway smooth muscle via multiple PKA- and EP2 receptor-dependent mechanisms. Biochemistry 2005 44 42 13771 13782 2-s2.0-27144543173 10.1021/bi051255y (Pubitemid 41507458)
31. Shore S. A., Laporte J., Hall I. P., Hardy E., Panettieri R. A., Effect of IL-1 β on responses of cultured human airway smooth muscle cells to bronchodilator agonists. American Journal of Respiratory Cell and Molecular Biology 1997 16 6 702 712 2-s2.0-0031155267 (Pubitemid 127498946)
32. Terwilliger R. Z., Beitner-Johnson D., Sevarino K. A., Crain S. M., Nestler E. J., A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Research 1991 548 1-2 100 110 2-s2.0-0025760593
33. Fedynyshyn J. P., Lee N. M., μ type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase. FEBS Letters 1989 253 1-2 23 27 2-s2.0-0024341312 10.1016/0014-5793(89)80921-4 (Pubitemid 19212540)
34. Bagley E. E., Gerke M. B., Vaughan C. W., Hack S. P., Christie M. J., GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron 2005 45 3 433 445 2-s2.0-12344316960 10.1016/j.neuron.2004.12.049 (Pubitemid 40188210)
35. Lane-Ladd S. B., Pineda J., Boundy V. A., Pfeuffer T., Krupinski J., Aghajanian G. K., Nestler E. J., CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. Journal of Neuroscience 1997 17 20 7890 7901 2-s2.0-0030803695 (Pubitemid 27426226)
36. Punch L. J., Self D. W., Nestler E. J., Taylor J. R., Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. Journal of Neuroscience 1997 17 21 8520 8527 2-s2.0-0030728473 (Pubitemid 27461073)
37. Maldonado R., Valverde O., Garbay C., Roques B. P., Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal. Naunyn-Schmiedeberg's Archives of Pharmacology 1995 352 5 565 575 2-s2.0-0028829387
38. Jolas T., Aghajanian G. K., Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Research 1997 755 2 229 245 2-s2.0-0030898428 10.1016/S0006- 8993(97)00103-0 (Pubitemid 27196329)
39. Hacker J., Pedersen N. P., Chieng B. C. H., Keay K. A., Christie M. J., Enhanced Fos expression in glutamic acid decarboxylase immunoreactive neurons of the mouse periaqueductal grey during opioid withdrawal. Neuroscience 2006 137 4 1389 1396 2-s2.0-31144443143 10.1016/j.neuroscience.2005.10.052 (Pubitemid 43133162)
40. Williams J. T., Christie M. J., Manzoni O., Cellular and synaptic adaptations mediating opioid dependence. Physiological Reviews 2001 81 1 299 343 2-s2.0-0035138995 (Pubitemid 32096178)
41. Hack S. P., Vaughan C. W., Christie M. J., Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology 2003 45 5 575 584 2-s2.0-0042572492 10.1016/S0028-3908(03)00205-3 (Pubitemid 36980814)
42. Bagley E. E., Hacker J., Chefer V. I., Mallet C., McNally G. P., Chieng B. C. H., Perroud J., Shippenberg T. S., Christie M. J., Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors. Nature Neuroscience 2011 14 12 1548 1554 2-s2.0-82255183147 10.1038/nn.2940
43. Stern P., Glia. Glee for glia. Introduction. Science 2010 330 6005 773 2-s2.0-79952064015
44. Tower D. B., Young O. M., The activities of butyrylcholinesterase and carbonic anhydrase, the rate of anaerobic glycolysis, and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale. Journal of Neurochemistry 1973 20 269 278 2-s2.0-0015838278
45. Rossi D., Volterra A., Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Research Bulletin 2009 80 4-5 224 232 2-s2.0-70349425672 10.1016/j.brainresbull.2009.07.012
46. Halassa M. M., Fellin T., Haydon P. G., The tripartite synapse: roles for gliotransmission in health and disease. Trends in Molecular Medicine 2007 13 2 54 63 2-s2.0-33846621575 10.1016/j.molmed.2006.12.005 (Pubitemid 46186152)
47. Bains J. S., Oliet S. H. R., Glia: they make your memories stick! Trends in Neurosciences 2007 30 8 417 424 2-s2.0-34447618766 10.1016/j.tins.2007.06.007 (Pubitemid 47088717)
48. Hutchinson M. R., Bland S. T., Johnson K. W., Rice K. C., Maier S. F., Watkins L. R., Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. TheScientificWorldJOURNAL 2007 7 2 98 111 2-s2.0-37349118058 (Pubitemid 350292608)
49. Ledeboer A., Hutchinson M. R., Watkins L. R., Johnson K. W., Ibudilast (AV-411): a new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opinion on Investigational Drugs 2007 16 7 935 950 2-s2.0-34447529270 10.1517/13543784.16.7.935 (Pubitemid 47078775)
50. Hutchinson M. R., Lewis S. S., Coats B. D., Skyba D. A., Crysdale N. Y., Berkelhammer D. L., Brzeski A., Northcutt A., Vietz C. M., Judd C. M., Maier S. F., Watkins L. R., Johnson K. W., Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain, Behavior, and Immunity 2009 23 2 240 250 2-s2.0-58849159101 10.1016/j.bbi.2008. 09.012
51. Song P., Zhao Z. Q., The involvement of glial cells in the development of morphine tolerance. Neuroscience Research 2001 39 3 281 286 2-s2.0-0035111016 10.1016/S0168-0102(00)00226-1 (Pubitemid 32186379)
52. Raghavendra V., Rutkowski M. D., Deleo J. A., The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. Journal of Neuroscience 2002 22 22 9980 9989 2-s2.0-0037112041 (Pubitemid 35332883)
53. Johnston I. N., Milligan E. D., Wieseler-Frank J., Frank M. G., Zapata V., Campisi J., Langer S., Martin D., Green P., Fleshner M., Leinwand L., Maier S. F., Watkins L. R., A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. Journal of Neuroscience 2004 24 33 7353 7365 2-s2.0-7244226284 10.1523/JNEUROSCI.1850-04.2004 (Pubitemid 39100704)
54. Raghavendra V., Tanga F. Y., DeLeo J. A., Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 2004 29 2 327 334 2-s2.0-0842286586 10.1038/sj.npp.1300315 (Pubitemid 38175151)
55. Lewis S. S., Hutchinson M. R., Coats B. D., AV411, a blood brain barrier permeable glial activation inhibitor, reduces morphine withdrawal behaviors in rats. Proceedings of the Society for Neuroscience 2006 765 762
56. Hutchinson M. R., Lewis S. S., Coats B. D., Rezvani N., Zhang Y., Wieseler J. L., Somogyi A. A., Yin H., Maier S. F., Rice K. C., Watkins L. R., Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience 2010 167 3 880 893 2-s2.0-77951299280 10.1016/j.neuroscience.2010.02.011
57. Hutchinson M. R., Loram L. C., Zhang Y., Shridhar M., Rezvani N., Berkelhammer D., Phipps S., Foster P. S., Landgraf K., Falke J. J., Rice K. C., Maier S. F., Yin H., Watkins L. R., Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience 2010 168 2 551 563 2-s2.0-77952883464 10.1016/j.neuroscience.2010. 03.067
58. Wang X., Loram L. C., Ramos K., De Jesus A. J., Thomas J., Cheng K., Reddy A., Somogyi A. A., Hutchinson M. R., Watkins L. R., Yin H., Morphine activates neuroinflammation in a manner parallel to endotoxin. Proceedings of the National Academy of Sciences of the United States of America 2012 109 16 6325 6330 2-s2.0-84860012585 10.1073/pnas.1200130109
59. Saito O., Svensson C. I., Buczynski M. W., Wegner K., Hua X. Y., Codeluppi S., Schaloske R. H., Deems R. A., Dennis E. A., Yaksh T. L., Spinal glial TLR4-mediated nociception and production of prostaglandin E2 and TNF. British Journal of Pharmacology 2010 160 7 1754 1764 2-s2.0-77954347484 10.1111/j.1476-5381.2010.00811.x
60. Bettoni I., Comelli F., Rossini C., Granucci F., Giagnoni G., Peri F., Costa B., Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. GLIA 2008 56 12 1312 1319 2-s2.0-51349166320 10.1002/glia.20699
61. Volterra A., Meldolesi J., Astrocytes, from brain glue to communication elements: the revolution continues. Nature Reviews Neuroscience 2005 6 8 626 640 2-s2.0-23044435896 10.1038/nrn1722 (Pubitemid 41059337)
62. Hutchinson M. R., Zhang Y., Shridhar M., Evans J. H., Buchanan M. M., Zhao T. X., Slivka P. F., Coats B. D., Rezvani N., Wieseler J., Hughes T. S., Landgraf K. E., Chan S., Fong S., Phipps S., Falke J. J., Leinwand L. A., Maier S. F., Yin H., Rice K. C., Watkins L. R., Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain, Behavior, and Immunity 2010 24 1 83 95 2-s2.0-71749111875 10.1016/j.bbi.2009.08.004
63. Pickering M., Cumiskey D., O'Connor J. J., Actions of TNF- α on glutamatergic synaptic transmission in the central nervous system. Experimental Physiology 2005 90 5 663 670 2-s2.0-26044438460 10.1113/expphysiol.2005.030734 (Pubitemid 41406053)
64. Garcia-Segura L. M., Lorenz B., DonCarlos L. L., The role of glia in the hypothalamus: implications for gonadal steroid feedback and reproductive neuroendocrine output. Reproduction 2008 135 4 419 429 2-s2.0-42549103674 10.1530/REP-07-0540 (Pubitemid 351578148)
65. Bushong E. A., Martone M. E., Jones Y. Z., Ellisman M. H., Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. Journal of Neuroscience 2002 22 1 183 192 2-s2.0-0036139877 (Pubitemid 34033496)
66. Halassa M. M., Fellin T., Takano H., Dong J. H., Haydon P. G., Synaptic islands defined by the territory of a single astrocyte. Journal of Neuroscience 2007 27 24 6473 6477 2-s2.0-34250317399 10.1523/JNEUROSCI.1419-07.2007 (Pubitemid 46920364)
67. Araque A., Parpura V., Sanzgiri R. P., Haydon P. G., Tripartite synapses: Glia, the unacknowledged partner. Trends in Neurosciences 1999 22 5 208 215 2-s2.0-0033135292 10.1016/S0166-2236(98)01349-6 (Pubitemid 29202082)
68. Halassa M. M., Haydon P. G., Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annual Review of Physiology 2009 72 335 355 2-s2.0-77951929051 10.1146/annurev-physiol-021909-135843
69. Liu Q. S., Xu Q., Arcuino G., Kang J., Nedergaard M., Astrocyte-mediated activation of neuronal kainate receptors. Proceedings of the National Academy of Sciences of the United States of America 2004 101 9 3172 3177 2-s2.0-1542357665 10.1073/pnas.0306731101 (Pubitemid 38327753)
70. Narita M., Suzuki M., Kuzumaki N., Miyatake M., Suzuki T., Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine. Annals of the New York Academy of Sciences 2008 1141 96 104 2-s2.0-54949129761 10.1196/annals.1441.032
71. Watkins L. R., Hutchinson M. R., Milligan E. D., Maier S. F., 'Listening' and 'talking' to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Research Reviews 2007 56 1 148 169 2-s2.0-36049011866 10.1016/j.brainresrev.2007.06.006 (Pubitemid 350100866)
72. Zhang R. X., Li A., Liu B., Wang L., Ren K., Zhang H., Berman B. M., Lao L., IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 2008 135 3 232 239 2-s2.0-40049094003 10.1016/j.pain.2007.05.023 (Pubitemid 351324021)
73. Nakagawa T., Satoh M., Involvement of glial glutamate transporters in morphine dependence. Annals of the New York Academy of Sciences 2004 1025 383 388 2-s2.0-10444276594 10.1196/annals.1307.047 (Pubitemid 39643885)
74. Srinivasan D., Yen J. H., Joseph D. J., Friedman W., Cell type-specific interleukin-1 β signaling in the CNS. Journal of Neuroscience 2004 24 29 6482 6488 2-s2.0-3242781549 10.1523/JNEUROSCI.5712-03.2004 (Pubitemid 38971695)
75. Guo W., Wang H., Watanabe M., Shimizu K., Zou S., LaGraize S. C., Wei F., Dubner R., Ren K., Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. Journal of Neuroscience 2007 27 22 6006 6018 2-s2.0-34249795149 10.1523/JNEUROSCI.0176-07.2007 (Pubitemid 46849761)
76. De A., Krueger J. M., Simasko S. M., Tumor necrosis factor α increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons. Brain Research 2003 981 1-2 133 142 2-s2.0-0141522973 10.1016/S0006-8993(03)02997-4 (Pubitemid 37281228)
77. Jin X., Gereau R. W., Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor- α Journal of Neuroscience 2006 26 1 246 255 2-s2.0-30644463076 10.1523/JNEUROSCI.3858-05.2006 (Pubitemid 43089538)
78. Grassi F., Mileo A. M., Monaco L., Punturieri A., Santoni A., Eusebi F., TNF- α increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons. Brain Research 1994 659 1-2 226 230 2-s2.0-0028168159
79. Zhang L., Berta T., Xu Z. Z., Liu T., Park J. Y., Ji R. R., TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2. Pain 2011 152 2 419 427 2-s2.0-78651498932 10.1016/j.pain.2010.11.014
80. Stellwagen D., Beattie E. C., Seo J. Y., Malenka R. C., Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor- α Journal of Neuroscience 2005 25 12 3219 3228 2-s2.0-16244376446 10.1523/JNEUROSCI.4486-04.2005 (Pubitemid 40463557)
81. Liu J. G., Anand K. J. S., Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Research Reviews 2001 38 1-2 1 19 2-s2.0-0035696235 10.1016/S0165-0173(01)00057-1 (Pubitemid 34066494)
82. Ren X., Noda Y., Mamiya T., Nagai T., Nabeshima T., A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Behavioural Brain Research 2004 152 2 243 250 2-s2.0-2942627934 10.1016/j.bbr.2003.10.013 (Pubitemid 38757894)
83. Cao J. L., He J. H., Ding H. L., Zeng Y. M., Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats. Pain 2005 118 3 336 349 2-s2.0-28644433404 10.1016/j.pain.2005.09.006 (Pubitemid 41752991)
84. Muller D. L., Unterwald E. M., In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. Journal of Pharmacology and Experimental Therapeutics 2004 310 2 774 782 2-s2.0-3342917288 10.1124/jpet.104.066548 (Pubitemid 38988924)
85. Núez C., Castells M. T., Laorden M. L., Milanés M. V., Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system. Naunyn-Schmiedeberg's Archives of Pharmacology 2008 378 4 407 420 2-s2.0-51749116935 10.1007/s00210-008-0304-9
86. Nestler E. J., Molecular neurobiology of addiction. American Journal on Addictions 2001 10 3 201 217 2-s2.0-0034834576 10.1080/105504901750532094 (Pubitemid 32879087)
87. Maldonado R., Blendy J. A., Tzavara E., Gass P., Roques B. P., Hanoune J., Schütz G., Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 1996 273 5275 657 659 2-s2.0-0029764770 (Pubitemid 26262121)
88. Widnell K. L., Russell D. S., Nestler E. J., Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proceedings of the National Academy of Sciences of the United States of America 1994 91 23 10947 10951 2-s2.0-0027997104 10.1073/pnas.91.23.10947 (Pubitemid 24349602)
89. Shaw-Lutchman T. Z., Barrot M., Wallace T., Gilden L., Zachariou V., Impey S., Duman R. S., Storm D., Nestler E. J., Regional and cellular mapping of camp response element-mediated transcription during naltrexone-precipitated morphine withdrawal. Journal of Neuroscience 2002 22 9 3663 3672 2-s2.0-0036581180 (Pubitemid 37465771)
90. Blendy J. A., Maldonado R., Genetic analysis of drug addiction: the role of cAMP response element binding protein. Journal of Molecular Medicine 1998 76 2 104 110 2-s2.0-0031931413 10.1007/s001090050197 (Pubitemid 28085089)
91. Nestler E. J., Is there a common molecular pathway for addiction? Nature Neuroscience 2005 8 11 1445 1449 2-s2.0-27644454004 10.1038/nn1578 (Pubitemid 41573654)
92. Anthony I. C., Arango J. C., Stephens B., Simmonds P., Bell J. E., The effects of illicit drugs on the HIV infected brain. Frontiers in Bioscience 2008 13 4 1294 1307 2-s2.0-38449096356 10.2741/2762 (Pubitemid 351594711)
93. Ferguson S. M., Fasano S., Yang P., Brambilla R., Robinson T. E., Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity. Neuropsychopharmacology 2006 31 12 2660 2668 2-s2.0-33751119536 10.1038/sj.npp.1301014 (Pubitemid 44764163)
94. Johannessen M., Delghandi M. P., Moens U., What turns CREB on? Cellular Signalling 2004 16 11 1211 1227 2-s2.0-4444280871 10.1016/j.cellsig.2004.05.001 (Pubitemid 39165450)